Incyte (INCY) Capital Expenditures (2010 - 2026)

Incyte (INCY) reported Capital Expenditures of $10.2 million for Q1 2026, up 221.87% on a YoY basis from $3.2 million in Q1 2025, and down 81.36% quarter-over-quarter from $54.7 million in Q4 2025.

Incyte (INCY) Capital Expenditures (2010 - 2026) Analysis & Trends

Incyte has reported Capital Expenditures for 17 years, with the latest figure at $10.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures rose 221.87% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $65.9 million (up 1124.19% YoY), and the FY2025 full-year result was $58.9 million, up 2166.73% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $10.2 million, down from $54.7 million in the prior quarter.
  • The five-year high for Capital Expenditures was $54.7 million in Q4 2025, with the low at -$53.1 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $6.3 million across 5 years, with a median of $3.2 million in 2025.
  • Annual changes were most pronounced in 2023 — Capital Expenditures slumped 169.15% — and 2025, when it surged 5913.92%.
  • Incyte's Capital Expenditures stood at -$53.1 million in 2022, then surged by 161.2% to $32.5 million in 2023, then tumbled by 102.9% to -$941000.0 in 2024, then surged by 5913.92% to $54.7 million in 2025, then tumbled by 81.36% to $10.2 million in 2026.
  • The last three Capital Expenditures figures came in at $10.2 million (Q1 2026), $54.7 million (Q4 2025), and $112000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 10.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.20 Mn
Mar 31, 2026 10.20 Mn
Dec 31, 2025 54.71 Mn
Dec 31, 2025 54.71 Mn
Sep 30, 2025 112,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 877,000.00
Jun 30, 2025 877,000.00
Mar 31, 2025 3.17 Mn
Mar 31, 2025 3.17 Mn
Dec 31, 2024 -941,000.00
Dec 31, 2024 -941,000.00
Sep 30, 2024 2.74 Mn
Sep 30, 2024 2.74 Mn
Jun 30, 2024 417,000.00
Jun 30, 2024 417,000.00
Mar 31, 2024 383,000.00
Mar 31, 2024 383,000.00
Dec 31, 2023 32.48 Mn
Dec 31, 2023 32.48 Mn